Literature DB >> 19833034

Survey of postharvest-processed oysters in the United States for levels of Vibrio vulnificus and Vibrio parahaemolyticus.

Angelo Depaola1, Jessica L Jones, Kathy E Noe, Robin H Byars, John C Bowers.   

Abstract

From June through October 2004, the U.S. Food and Drug Administration collected oysters (61 samples) that had been subjected to postharvest processing (PHP) methods, including mild heat treatment, freezing, and high hydrostatic pressure, from processors and retail markets in various states to determine Vibrio vulnificus and V. parahaemolyticus levels. Presence in a 25-g sample and most probable number (MPN) using standard enrichment and selective isolation procedures were utilized. Suspect colonies were isolated and identified using DNA probe colony hybridization. Neither species of vibrio was detected in 25-g portions of most samples regardless of the PHP. The lowest frequency of isolation of either pathogen (<10%) was observed with the mild heat process. Few (12 to 13%) frozen samples collected at the processor but not at retail contained >30 MPN/g of either pathogen. The mean levels of either organism in PHP oysters observed in the present study were 5 to 6 log less than in unprocessed raw Gulf Coast oysters. Of the 70 V. vulnificus isolates examined, only 5 possessed the putative virulence marker, type B 16S rRNA. Neither the thermostable direct hemolysin (tdh) nor the tdh-related hemolysin (trh) virulence gene was detected in any of the 40 V. parahaemolyticus isolates examined in the present study. These data suggest that if there is any selective advantage to pathogenic strains of V. vulnificus and V. parahaemolyticus, these differences are minimal. These results indicate that all PHP treatments greatly reduce exposure of V. vulnificus and V. parahaemolyticus to raw-oyster consumers. Consequently, these PHP oysters pose a much lower risk of illness to consumers due to these pathogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833034     DOI: 10.4315/0362-028x-72.10.2110

Source DB:  PubMed          Journal:  J Food Prot        ISSN: 0362-028X            Impact factor:   2.077


  7 in total

1.  Long-term study of Vibrio parahaemolyticus prevalence and distribution in New Zealand shellfish.

Authors:  C D Cruz; D Hedderley; G C Fletcher
Journal:  Appl Environ Microbiol       Date:  2015-01-23       Impact factor: 4.792

2.  Ecology of Vibrio parahaemolyticus and Vibrio vulnificus in the coastal and estuarine waters of Louisiana, Maryland, Mississippi, and Washington (United States).

Authors:  Crystal N Johnson; John C Bowers; Kimberly J Griffitt; Vanessa Molina; Rachel W Clostio; Shaofeng Pei; Edward Laws; Rohinee N Paranjpye; Mark S Strom; Arlene Chen; Nur A Hasan; Anwar Huq; Nicholas F Noriea; D Jay Grimes; Rita R Colwell
Journal:  Appl Environ Microbiol       Date:  2012-08-03       Impact factor: 4.792

3.  Increasing rates of vibriosis in the United States, 1996-2010: review of surveillance data from 2 systems.

Authors:  Anna Newton; Magdalena Kendall; Duc J Vugia; Olga L Henao; Barbara E Mahon
Journal:  Clin Infect Dis       Date:  2012-06       Impact factor: 9.079

Review 4.  Insight Into the Origin and Evolution of the Vibrio parahaemolyticus Pandemic Strain.

Authors:  Romilio T Espejo; Katherine García; Nicolas Plaza
Journal:  Front Microbiol       Date:  2017-07-24       Impact factor: 5.640

Review 5.  Food Safety Impacts from Post-Harvest Processing Procedures of Molluscan Shellfish.

Authors:  George L Baker
Journal:  Foods       Date:  2016-04-18

6.  Impact of 2003 state regulation on raw oyster-associated Vibrio vulnificus illnesses and deaths, California, USA.

Authors:  Duc J Vugia; Farzaneh Tabnak; Anna E Newton; Michael Hernandez; Patricia M Griffin
Journal:  Emerg Infect Dis       Date:  2013-08       Impact factor: 6.883

7.  Incidence and trends of infection with pathogens transmitted commonly through food - foodborne diseases active surveillance network, 10 U.S. sites, 1996-2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-04-19       Impact factor: 17.586

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.